2026-05-29

A New Start, A New Journey

Usynova's Zhongshan Headquarters Officially Opens, Usynova Enters a New Phase of Scaled Development

VIEW MORE

2021-08-05

Usynova and Insilico Medicine Announce Strategic Partnership on Accelerating R&D of Small Molecule Innovative Drug with AI

Shanghai, China, August 5, 2021 - Insilico Medicine, an industry leader in artificial intelligence for drug discovery, and Usynova announced to reach strategic cooperation.   The agreement outl

VIEW MORE

2021-04-10

Usynova and WuXi AppTec Sign a Collaboration Agreement on Class 1 Innovative Drugs

On April 8, 2021, Usynova Pharmaceuticals Ltd. and Wuxi Apptec Co., Ltd., a subsidiary of WuXi AppTec, signed a cooperation agreement on Class 1 innovative drugs in Shanghai. The signing ceremony was

VIEW MORE